Los Angeles Capital Management LLC Biocryst Pharmaceuticals Inc Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 101,188 shares of BCRX stock, worth $915,751. This represents 0.0% of its overall portfolio holdings.
Number of Shares
101,188
Previous 86,533
16.94%
Holding current value
$915,751
Previous $657,000
15.68%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding BCRX
# of Institutions
278Shares Held
167MCall Options Held
802KPut Options Held
989K-
Vanguard Group Inc Valley Forge, PA21.9MShares$198 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$181 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$107 Million1.3% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$82.2 Million4.33% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY8.14MShares$73.7 Million1.52% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.68B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...